Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cynosure Inc (NASDAQ:CYNO)

35.14
Delayed Data
As of Feb 12
 +0.12 / +0.34%
Today’s Change
28.20
Today|||52-Week Range
45.05
-21.33%
Year-to-Date

Today’s Trading

Previous close35.02
Today’s open35.48
Day’s range34.71 - 36.20
Volume318,283
Average volume (3 months)204,125
Market cap$798.6M
Dividend yield--
Data as of 4:00pm ET, 02/12/2016

Growth & Valuation

Earnings growth (last year)-50.35%
Earnings growth (this year)+28.04%
Earnings growth (next 5 years)+19.30%
Revenue growth (last year)+16.11%
P/E ratio24.9
Price/Sales2.98
Price/Book--

Competitors

 Today’s
change
Today’s
% change
MDXGMiMedx Group Inc+0.16+2.15%
XLRNAcceleron Pharma Inc+0.58+2.34%
CNMDConmed Corp+0.49+1.36%
HTWRHeartWare Internatio...-0.91-2.67%
Data as of 4:00pm ET, 02/12/2016

Financials

Next reporting dateMay 3, 2016
EPS forecast (this quarter)$0.17
Annual revenue (last year)$339.5M
Annual profit (last year)$15.8M
Net profit margin4.66%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman &
Chief Executive Officer
Michael R. Davin
President, COO, CFO, Treasurer &
Executive VP
Timothy W. Baker
Corporate headquarters
Westford, Massachusetts

Forecasts

Partner Offers